LAMISIL
LOE ApproachingNDATOPICALCREAM
Approved
Dec 1992
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 3h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LAMISIL (terbinafine) is a topical antifungal cream approved in 1992 for treatment of fungal skin infections. It works by inhibiting fungal cell membrane synthesis, making it effective against dermatophytes and other fungal pathogens. The product is a mature, well-established small-molecule therapeutic in the dermatology space.
LOE Approaching
With LOE approaching and moderate competitive pressure (30/100), the brand team is likely focused on lifecycle extension and cost management rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment
30 enrolled
Candidiasis, OralHIV Infections
Career Relevance
Working on LAMISIL offers limited career acceleration due to its mature, LOE-approaching status and minimal linked job openings. Career value lies primarily in defensive commercial strategies, market access expertise, and operational efficiency rather than growth or innovation.
Brand Manager
Worked on LAMISIL at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.